Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis

References

• LaurellC-BErikssonSThe electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiencyScand J Clin Lab Invest196315132140
   Web of Science ®Google Scholar
• SharpHLBridgesRAKrivitWFreierEFCirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorderJ Lab Clin Med19697369349394182334
   PubMed Web of Science ®Google Scholar
• KingMAStoneJADiazPTα1-antitrypsin deficiency: evaluation of bronchiectasis with CTRadiology199619911371418633137
   PubMed Web of Science ®Google Scholar
• EdenEMitchellDMehlmanBAtopy, asthma, and emphysema in patients with severe alpha-1-antitrypsin deficiencyAm J Respir Crit Care Med1997156168749230728
   PubMed Web of Science ®Google Scholar
• GriffithMELovegroveJUGaskinGWhitehouseDBPuseyCDC-anti-neutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and the P-antineutrophil cytoplasmic antibody positivity with the S alleleNephrol Dial Transplant19961134384438671812
   PubMed Web of Science ®Google Scholar
• BleuminkEKlokkeAHRelationship between Weber-Christian panniculitis and the ZZ phenotype of alpha1-antitrypsinArch Dermatol Res198527743283293873915
   PubMed Web of Science ®Google Scholar
• CichyJPotempaJTravisJBiosynthesis of α1-proteinase inhibitor by human-derived epithelial cellsJ Biol Chem199727213825082559079644
   PubMed Web of Science ®Google Scholar
• VenembrePBouttenASetaNSecretion of alpha 1-antitrypsin by alveolar epithelial cellsFEBS Lett19943462–31711748013628
   PubMed Web of Science ®Google Scholar
• GeboesKRayMBRutgeertsPCalleaFDesmetVJVantrappenGMorphological identification of alpha-1-antitrypsin in the human small intestineHistopathology19826155607035326
   PubMed Web of Science ®Google Scholar
• PaakkoPKirbyMdu BoisRMGillissenAFerransVJCrystalRGActivated neutrophils secrete stored alpha-1 antitrypsinAm J Respir Crit Care Med19961546 pt 1182918338970377
   PubMed Web of Science ®Google Scholar
• CohenABInterrelationships between the human alveolar macrophage and alpha-1-antitrypsinJ Clin Invest19735211279327994201266
   PubMed Web of Science ®Google Scholar
• CoxDWWooSLMansfieldTDNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for the deficiency allele PI ZNature1985316602379812989709
   PubMed Web of Science ®Google Scholar
• BlancoIde SerresFJFernández-BustilloELaraBMiravitllesMEstimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countriesEur Respir J2006271778416387939
   PubMed Web of Science ®Google Scholar
• de SerresFJWorldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveysChest200212251818182912426287
   PubMed Web of Science ®Google Scholar
• SeyamaKNukiwaTSoumaSShimizuKKiraSAlpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in JapanAm J Respir Crit Care Med19951526 pt 1211921268520784
   PubMed Web of Science ®Google Scholar
• FerrarottiIBaccheschiJZorzettoMTinelliCCordaLBalbiBPrevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiencyJ Med Genet200542328228715744045
   PubMed Web of Science ®Google Scholar
• LeeJHBrantlyMMolecular mechanisms of alpha1-antitrypsin null allelesRespir Med200094Suppl CS71110954248
   PubMed Web of Science ®Google Scholar
• LomasDAEvansDLFinchJTCarrellRWThe mechanism of Z α1-antitrypsin accumulation in the liverNature199235763796056071608473
   PubMed Web of Science ®Google Scholar
• LarssonCNatural history and life expectancy in severe alpha1-antitrypsin deficiency, PiZActa Med Scand17982045345351309708
   PubMedGoogle Scholar
• LiebermanJWinterBSastreAAlpha 1-antitrypsin Pi-types in 965 COPD patientsChest19868933703733485034
   PubMed Web of Science ®Google Scholar
• GadekJEKleinHGHollandPVCrystalRGReplacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjectsJ Clin Invest1981685115811657028785
   PubMed Web of Science ®Google Scholar
• GøtzschePCJohansenHKIntravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung diseaseCochrane Database Syst Rev20107CD00785120614465
   PubMed Web of Science ®Google Scholar
• YuM-HLeeKNKimJThe Z type variation of human α1-antitrypsin causes a protein folding defectNat Struct Biol1995253633677664092
   PubMedGoogle Scholar
• KangHALeeKNYuMHFolding and stability of the Z and Siiyama genetic variants of human α1-antitrypsinJ Biol Chem199727215105168995291
   PubMed Web of Science ®Google Scholar
• WuYSwuliusMTMoremenKWSifersRNElucidation of the molecular logic by which misfolded α1-antitrypsin is preferentially selected for degradationProc Natl Acad Sci U S A2003100148229823412815101
   PubMed Web of Science ®Google Scholar
• KroegerHMirandaEMacLeodIEndoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpinsJ Biol Chem200928434227932280219549782
   PubMed Web of Science ®Google Scholar
• QuDTeckmanJHOmuraSPerlmutterDHDegradation of a mutant secretory protein, α1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activityJ Biol Chem19962713722791227958798455
   PubMed Web of Science ®Google Scholar
• LeAFerrellGADishonDSLeQQSiferRNSoluble aggregates of the human PiZ á1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesisJ Biol Chem19922672107210801530934
   PubMed Web of Science ®Google Scholar
• GooptuBHazesBChangWSInactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational diseaseProc Natl Acad Sci U S A2000971677210618372
   PubMed Web of Science ®Google Scholar
• MahadevaRAtkinsonCLiZPolymers of Z α1-antitrypsin co- localize with neutrophils in emphysematous alveoli and are chemotactic in vivoAm J Path2005166237738615681822
   PubMed Web of Science ®Google Scholar
• GrossBGrebeMWenckerMStollerJKBjurstenLMJanciauskieneSNew findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapyDermatology2009218437037519218787
   PubMed Web of Science ®Google Scholar
• MorrisHMorganMDWoodsAANCA-associated vasculitis is linked to carriage of the Z allele of α1-antitrypsin and its polymersAnn Rheum Dis2011 In press
   Web of Science ®Google Scholar
• RonDWalterPSignal integration in the endoplasmic reticulum unfolded protein responseNat Rev Mol Cell Biol20078751952917565364
   PubMed Web of Science ®Google Scholar
• PahlHLSesterMBurgertHGBaeuerlePAActivation of transcription factor NF-kappaB by the adenvirus E3/19 K protein requires its ER retentionJ Cell Biol199613245115228647884
   PubMed Web of Science ®Google Scholar
• GrahamKSLeASifersRNAccumulation of the insoluble PiZ variant of human α1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiPJ Biol Chem19902653320463204682122976
   PubMed Web of Science ®Google Scholar
• HidvegiTSchmidtBZHalePPerlmutterDHAccumulation of mutant α1-antitrypsin Z in the endoplasmic reticulum activates caspases -4 and -12, NF-κB, and BAP31 but not the unfolded protein responseJ Biol Chem200528047390023901516183649
   PubMed Web of Science ®Google Scholar
• DaviesMJMirandaERousselBDKaufmanRJMarciniakSJLomasDANeuroserpin polymers activate NF-kappaB by a calcium signalling pathway that is independent of the unfolded protein responseJ Biol Chem200928427182021820919423713
   PubMed Web of Science ®Google Scholar
• LawlessMWGreeneCMMulgrewATaggartCCO’NeillSJMcElvaneyNGActivation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z α1-antitrypsin deficiencyJ Immunol200417295722572615100318
   PubMed Web of Science ®Google Scholar
• RudnickDALiaoYAnJKMugliaLJPerlmutterDHTeckmanJHAnalyses of hepatocellular proliferation in a mouse model of α-1-antitrypsin deficiencyHepatology20043941048105515057909
   PubMed Web of Science ®Google Scholar
• SvegerTLiver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infantsN Engl J Med197629424131613211083485
   PubMed Web of Science ®Google Scholar
• ErikssonSCarlsonJVelezRRisk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiencyN Engl J Med1986314127367393485248
   PubMed Web of Science ®Google Scholar
• HashemiMAlavianSMGhavamiSHigh prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in IranHepatol Res200533429229716260177
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory SocietyAmerican Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiencyAm J Respir Crit Care Med2003168781890014522813
   PubMed Web of Science ®Google Scholar
• BowlusCLWillnerIZernMAFactors associated with advanced liver disease in adults with alpha-1-antitrypsin deficiencyClin Gastroenterol Hepatol20053439039615822045
   PubMed Web of Science ®Google Scholar
• KemmerNKaiserTZachariasVNeffGWAlpha-1-antitrpysin deficiency: outcomes after liver transplantationTransplant Proc20084051492149418589136
   PubMed Web of Science ®Google Scholar
• McElvaneyNGStollerJKBuistASBaseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study GroupChest199711123944039041988
   PubMed Web of Science ®Google Scholar
• StollerJKSmithPYangPSprayJPhysical and social impact of alpha 1-antitrypsin deficiency: results of a surveyCleve Clin J Med19946164614677828337
   PubMed Web of Science ®Google Scholar
• StollerJKSandhausRATurinoGDicksonRRodgersKStrangeCDelay in diagnosis of alpha1-antitrypsin deficiency: a continuing problemChest200512841989199416236846
   PubMed Web of Science ®Google Scholar
• JanusEDPhillipsNTCarrellRWSmoking, lung function, and alpha 1-antitrypsin deficiencyLancet1985184211521542857224
   PubMed Web of Science ®Google Scholar
• DowsonLJGuestPJStockleyRALongitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with declineAm J Respir Crit Care Med200116410 pt 11805180911734427
   PubMed Web of Science ®Google Scholar
• MayerASStollerJKBucherBBOccupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiencyAm J Respir Crit Care Med20001622 pt 155353810934086
   PubMed Web of Science ®Google Scholar
• BamforthFJKalshekerNAAlpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneityJ Med Genet198825283872831367
   PubMed Web of Science ®Google Scholar
• StockleyRAMeasurement of soluble proteins in lung secretionsThorax19843942412476372152
   PubMed Web of Science ®Google Scholar
• ElliottPRBiltonDLomasDALung polymers in Z α-1-antitrypsin deficiency-related emphysemaAm J Respir Cell Mol Biol19981856706749569237
   PubMed Web of Science ®Google Scholar
• MulgrewATTaggartCCLawlessMWZ α-1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractantChest200412551952195715136414
   PubMed Web of Science ®Google Scholar
• AlamSLiZJanciauskieneSMahadevaROxidation of Z{alpha}1-antitrypsin by cigarette smoke induces polymerisation: a novel mechanism of early-onset emphysemaAm J Respir Cell Mol Biol2010 [Epub ahead of print]
   Web of Science ®Google Scholar
• ParmarJSMahadevaRReedBJPolymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysemaAm J Respir Cell Mol Biol200226672373012034572
   PubMed Web of Science ®Google Scholar
• WoolhouseISBayleyDLStockleyRASputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8Thorax200257870971412149532
   PubMed Web of Science ®Google Scholar
• HubbardRCFellsGGadekJPacholokSHumesJCrystalRGNeutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophagesJ Clin Invest19918838918971653278
   PubMed Web of Science ®Google Scholar
• OgushiFFellsGAHubbardRCStrausSDCrystalRGZ-type alpha 1-antitrypsin is less competent than M1-type alpha-1 antitrypsin as an inhibitor of neutrophil elastaseJ Clin Invest1987805136613743500183
   PubMed Web of Science ®Google Scholar
• JohnsonDTravisJThe oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive centerJ Biol Chem19792541040224026312289
   PubMed Web of Science ®Google Scholar
• LiZAlamSWangJSandstromCSJanciauskieneSMahadevaROxidized alpha1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysemaAm J Physiol Lung Cell Mol Physiol20092972L38840019525388
   PubMed Web of Science ®Google Scholar
• PetracheIFijalkowskaIMedlerTRAlpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosisAm J Pathol200616941155116617003475
   PubMed Web of Science ®Google Scholar
• BlancoILaraBde SerresFEfficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysemaOrphanet J Rare Dis201161421486454
   PubMed Web of Science ®Google Scholar
• WilckeJTDirksenAThe effect of inhaled glucocorticosteroids in emphysema due to alpha1-antitrypsin deficiencyRespir Med19979152752799176645
   PubMed Web of Science ®Google Scholar
• CordaLBertellaELa PianaGEBoniERedolfiSTantucciCInhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficieny-related COPDRespiration2008761616818319586
   PubMed Web of Science ®Google Scholar
• FishmanAMartinezFNaunheimA randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysemaN Engl J Med2003348212059207312759479
   PubMed Web of Science ®Google Scholar
• DauriatGMalHJebrakGFunctional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patientsInt J Chron Obstruct Pulmon Dis20061220120618046897
   PubMedGoogle Scholar
• RemundKFBartosikWWoodAEEganJJEndobronchial valve treatment in patients with advanced emphysema and alpha-1-antitrypsin deficiencyThorax200863Suppl VIIA12
   Google Scholar
• The International Society for Heart and Lung Transplantation Available at: http://www.ishlt.org/registriesAccessed March 2, 2011
   Google Scholar
• WewersMDCasolaroMASellersSEReplacement therapy for alpha 1-antitrypsin deficiency associated with emphysemaN Engl J Med198731617105510623494198
   PubMed Web of Science ®Google Scholar
• KueppersFThe role of augmentation therapy in alpha-1 antitrypsin deficiencyCurr Med Res Opin201127357958821226542
   PubMed Web of Science ®Google Scholar
• SilvermanEKSandhausRAClinical Practice: alpha1-antitrypsin deficiencyN Engl J Med2009360262749275719553648
   PubMed Web of Science ®Google Scholar
• StollerJKFallatRSchluchterMDAugmentation therapy with alpha1-antitrypsin: patterns of use and adverse eventsChest200312351425143412740257
   PubMed Web of Science ®Google Scholar
• SchmidtEWRascheBUlmerWTReplacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive diseaseAm J Med1988846A63693289388
   PubMed Web of Science ®Google Scholar
• CamposMAWannerAZhangGSandhausRATrends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003Chest200512831179118616162704
   PubMed Web of Science ®Google Scholar
• Feedback on Cochrane review; see ref 20 Available at: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD007851/frame.htmlAccessed August 4, 2011
   Google Scholar
• HutchinsonDCHughesMDAlpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?Eur Respir J19971010219121939387938
   PubMed Web of Science ®Google Scholar
• SchluchterMDStollerJKBarkerAFFeasibility of a clinical trial of augmentation therapy for α1-antitrypsin deficiencyAm J Respir Crit Care Med20001613 pt 179680110712324
   PubMed Web of Science ®Google Scholar
• SeersholmNWenckerMBanikNDoes α1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary α1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEur Respir J19971010226022639387950
   PubMed Web of Science ®Google Scholar
• The Alpha-1-Antitrypsin Deficiency Registry Study GroupSurvival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsinAm J Respir Crit Care Med1998158149599655706
   PubMed Web of Science ®Google Scholar
• WenckerMFuhrmannBBanikNKonietzkoNLongitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitorChest2001119373774411243951
   PubMed Web of Science ®Google Scholar
• TonelliARRouhaniFLiNSchreckPBrantlyMLAlpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue BankInt J Chron Obstruct Pulmon Dis2009444345220054436
   PubMedGoogle Scholar
• DirksenADijkmanJHMadsenFA randomized clinical trial of α1-antitrypsin augmentation therapyAm J Respir Crit Care Med19991605 pt 11468147210556107
   PubMed Web of Science ®Google Scholar
• HubbardRCSellersSCzerskiDStephensLCrystalRGBiochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiencyJAMA19882609125912643261353
   PubMed Web of Science ®Google Scholar
• DirksenAPiitulainenEParrDGExploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiencyEur Respir J20093361345135319196813
   PubMed Web of Science ®Google Scholar
• Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) DeficiencyClinicalTrials.gov Identifier: NCT00261833
   Google Scholar
• ChapmanKRBradiACPatersonDSlower lung function decline during augmentation therapy in patients with alpha 1-antitrypsin efficiency (A1ATD): results from the Canadian AIR registryProc Am Thorac Soc2005A808
   Google Scholar
• ChapmanKRStockleyRADawkinsCAugmentation therapy for alpha1-antitrypsin deficiency: a meta-analysisCOPD20096317718419811373
   PubMedGoogle Scholar
• StockleyRAParrDGPiitulainenETherapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometryRespir Res20101113620920370
   PubMed Web of Science ®Google Scholar
• LiebermanJAugmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting dataChest200011851480148511083705
   PubMed Web of Science ®Google Scholar
• CamposMAAlazemiSZhangGExacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapyRespir Med2009103101532153919464158
   PubMed Web of Science ®Google Scholar
• StockleyRABayleyDLUnsalIDowsonLJThe effect of augmentation therapy on bronchial inflammation in α1-antitrypsin deficiencyAm J Respir Crit Care Med2002165111494149812045122
   PubMed Web of Science ®Google Scholar
• DirksenAFriisMOlesenKPSkovgaardLTSorensenKProgressof emphysema in severe α1-antitrypsin deficiency as assessed by annual CTActa Radiol1997385826832
   Google Scholar
• VoulgariFCumminsPGardeckiTIBeechingNJStonePCStuartJSerum levels of acute phase and cardiac proteins after myocardial infarction, surgery and infectionBr Heart J19824843523566181800
   PubMedGoogle Scholar
• SchwarzenburgSJSharpHLBerrySAMantheiRDSeeligSHormonal regulation of serum alpha 1-antitrypsin and hepatic alpha 1-antitrypsin mRNA in ratsBiochem Biophys Res Commun198714739369413499151
   PubMed Web of Science ®Google Scholar
• MallyaMPhillipsRLSaldanhaSASmall molecules block the polymerization of Z α1-antitrypsin and increase the clearance of intracellular aggregatesJ Med Chem200750225357536317918823
   PubMed Web of Science ®Google Scholar
• MahadevaRChangWSDaffornTHeteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosisJ Clin Invest19991037999100610194472
   PubMed Web of Science ®Google Scholar
• MirandaEPerezJHadzicNA novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with α1-antitrypsin deficiencyHepatology20105231078108820583215
   PubMed Web of Science ®Google Scholar
• PollerWMerkleinFSchneider-RaspSMolecular characterization of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369 Leu), and Q0lisbon (Thr68Ile)Eur J Hum Genet19997332133110234508
   PubMed Web of Science ®Google Scholar
• FraizerGCHarroldTRHofkerMHCoxDWIn-frame single codon deletion in the Mmalton deficiency allele of α1-antitrypsinAm J Hum Genet19894468949022786335
   PubMed Web of Science ®Google Scholar
• CurielDTVogelmeierCHubbardRCStierLECrystalRGMolecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs alleleMol Cell Biol199010147561967187
   PubMed Web of Science ®Google Scholar
• MatsunagaEShiokawaSNakamuraHMaruyamaTTsudaKFukumakiYMolecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, MnichinanAm J Hum Gene1990463602612
   Web of Science ®Google Scholar
• FaberJ-PPollerWWeidingerSIdentification and DNA sequence analysis of 15 new alpha-1 antitrypsin variants, including 2 PiQO alleles and one deficient PiM alleleAm J Hum Genet1994556111311217977369
   PubMed Web of Science ®Google Scholar
• TakahashiHNukiwaTSatohKCharacterization of the gene and protein of the alpha 1-antitrypsin “deficiency” allele MprocidaJ Biol Chem19882633015528155343262617
   PubMed Web of Science ®Google Scholar
• JardiRRodriguez-FriasFLopez-TalaveraJCCharacterization of the new alpha-1-antitrypsin-deficient PI M-type allele, PI M(vall d’hebron) (Pro(369)-->Ser)Hum Hered200050532032110878477
   PubMed Web of Science ®Google Scholar
• ConiPPiliEConvertinoGMVarallo: a new M(Like) alpha 1-antitrypsin- deficient alleleDiagn Mol Pathol200312423723914639110
   PubMedGoogle Scholar
• OwenMCBrennanSOLewisJHCarrellRWMutation of antitrypsin to antithrombin. Alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorderN Engl J Med1983309126946986604220
   PubMed Web of Science ®Google Scholar
• FaberJPWeidingerSGoeddeHWOleKThe deficient alpha-I-antitrypsin phenotype PI P is associated with an A-to-T transversion in exon III of the geneAm J Hum Genet19894511611632787118
   PubMed Web of Science ®Google Scholar
• GrahamAKalshekerNANewtonCRBamforthFJPowellSJMarkhamAFMolecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp25614018 Val); PiMmalton (Phe5114018deletion) and PiI (Arg3914018Cys)Hum Genet198984155582606478
   PubMed Web of Science ®Google Scholar
• HildesheimJKinsleyGBissellMPierceJBrantlyMGenetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant PduarteHum Mutat1993232212288364590
   PubMed Web of Science ®Google Scholar
• ColiABigottiGAlpha-1-antitrypsin protease inhibitor SZ phenotype and liver cirrhosisAppl Pathol19897154602784975
   PubMedGoogle Scholar
• HolmeJStockleyRACT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiencyChest200913651284129019892672
   PubMed Web of Science ®Google Scholar
• BlancoIBustilloEFRodriguezMCDistribution of α1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysisClin Genet200160643144111846735
   PubMed Web of Science ®Google Scholar
• YuasaISugimotoYIchinoseMPI*S(iiyama), a deficiency gene of alpha 1-antitrypsin: evidence for the occurrence in western JapanJpn J Hum Genet19933821851918358043
   PubMedGoogle Scholar
• HolmesMDBrantlyMLFellsGACrystalRGAlpha 1-antitrypsin Wbethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variantBiochem Biophys Res Commun19901703101310202390072
   PubMed Web of Science ®Google Scholar
• JardiRRodriguezFMiravitllesMIdentification and molecular characterization of the new alpha-1-antitrypsin deficient allele PI Y barcelona (Asp256-->Val and Pro391-->His). Mutations in brief no.174. OnlineHum Mutat199812321310651487
   PubMedGoogle Scholar
• SørheimICBakkePGulsvikAα1-antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohortsChest201013851125113220595457
   PubMed Web of Science ®Google Scholar
• GraziadeiIWJosephJJWiesnerRHTherneauTMBattsKPPoraykoMKIncreased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiencyHepatology1998284105810639755243
   PubMed Web of Science ®Google Scholar
• WeidingerSJahnWCujnikFSchwarzfischerFAlpha-1-antitrypsin: evidence for a fifth PI M subtype and a new deficiency allele PI*Z augsburgHum Genet198571127293875547
   PubMed Web of Science ®Google Scholar
• WhitehouseDBAbbottCMLovegroveJUGenetic studies on a new deficiency gene (PI*Ztun) at the PI locusJ Med Genet198926127447492575668
   PubMed Web of Science ®Google Scholar
• GrahamAKalshekerNABamforthFJNewtonCRMarkhamAFMolecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly11514018Ser) and (Pi) Z Wrexham (Ser-1914018Leu)Hum Genet19908555375402227940
   PubMed Web of Science ®Google Scholar
• SatohKNukiwaTBrantlyMEmphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exonAm J Hum Genet198842177833257351
   PubMed Web of Science ®Google Scholar
• FraizerGCHarroldTRHofkerMHCoxDWIn-frame single codon deletion in the Mmalton deficiency allele of alpha 1-antitrypsinAm J Hum Genet19894468949022786335
   PubMed Web of Science ®Google Scholar
• ZorzettoMFerrarottiICampoIIdentification of a novel alpha1-antitrypsin null variant (Q0Cairo)Diagn Mol Pathol200514212112415905697
   PubMedGoogle Scholar
• BrantlyMLeeJHHildesheimJAlpha1-antitrypsin gene mutation hot spot associated with the formation of a retained and degraded null variantAm J Respir Cell Mol Biol19971632252319070606
   PubMed Web of Science ®Google Scholar
• NukiwaTTakahashiHBrantlyMCourtneyMCrystalRGalpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exonJ Biol Chem19872622511999120043040726
   PubMed Web of Science ®Google Scholar
• SifersRNBrashears-MacateeSKiddVJMuenschHWooSLA frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulumJ Biol Chem198826315733073353259232
   PubMed Web of Science ®Google Scholar
• TakahashiHCrystalRGAlpha 1-antitrypsin Null (isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exonsAm J Hum Genet19904734034131975477
   PubMed Web of Science ®Google Scholar
• FrazierGCSiewertsenMAHofkerMHBrubacherMGCoxDWA null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structureJ Clin Invest1990866187818842254451
   PubMed Web of Science ®Google Scholar
• CurielDBrantlyMCurielEStierLCrystalRGAlpha-1-antitrypsin deficiency caused by the alpha-1-antitrypsin nullmattawa geneJ Clin Invest1989834114411522539391
   PubMed Web of Science ®Google Scholar
• Vaz RodriguesLCostaFMarquesPMendonçaCRochaJSeixasSSevere α-1 antitrypsin deficiency caused by Q0(Ourém) allele: clinical features, haplotype characterization and historyClin Genet2011 [Epub ahead of print]
   Web of Science ®Google Scholar
• PollerWFaberJPWeidingerSOlekKDNA polymorphisms associated with a new alpha 1-antitrypsin PIQ0 variant (PIQ0riedenburg)Hum Genet19918655225241673114
   PubMed Web of Science ®Google Scholar
• LeeJNovoradovskayaNRundquistBRewineJSaltiniCBrantlyMAlpha-1-antitrypsin nonsense mutation associated with retained truncated protein and reduced mRNAMol Genet Metab19986342702809635295
   PubMed Web of Science ®Google Scholar
• LaubachVERyanWJBrantlyMCharacterization of a human alpha 1-antitrypsin null allele involving aberrant mRNA splicingHum Mol Genet199327100110058364536
   PubMed Web of Science ®Google Scholar
• LomasDABelorgeyDMallyaMMolecular mousetraps and the serpinopathiesBiochem Soc Trans200533pt 232133015787598
   PubMed Web of Science ®Google Scholar
• LomasDAFinchJTSeyamaKNukiwaTCarrellRWAlpha1-antitrypsin Siiyama (Ser53Phe). Further evidence for intracellular loop-sheet polymerizationJ Biol Chem19932682115333153358340361
   PubMed Web of Science ®Google Scholar